Peer-reviewed veterinary case report
Treatment outcomes for lymphoma in dogs using COPLA and LVP drugs
By Boyce, K L & Kitchell, B E·Published in Journal of the American Animal Hospital Association·2000·Veterinary Teaching Hospital, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Treatment of canine lymphoma with COPLA/LVP.
- Species:
- dog
Plain-English summary
Seventy-five dogs diagnosed with lymphoma received a combination of chemotherapy drugs, including L-asparaginase and vincristine, to treat their cancer. About 80% of the dogs had a complete response to the treatment, meaning their cancer went into remission, while a smaller number had partial or no response. The dogs that achieved complete remission lived a median of 36 weeks longer, compared to just four weeks for those with partial or no response. The treatment was generally well-tolerated, with low levels of toxicity reported.
People also search for: dog lymphoma treatment · chemotherapy for dogs · canine cancer survival rates · dog cancer remission duration · lymphoma in dogs prognosis
Abstract
Seventy-five dogs with cytopathologically or histopathologically confirmed lymphoma received L-asparaginase, vincristine, cyclophosphamide, prednisone, and doxorubicin (COPLA) induction followed by chlorambucil, vincristine, and prednisone (LVP) maintenance between January 1994 and June 1997. Toxicity was evaluated using the National Cancer Institute (NCI) toxicity criteria. Age, weight, sex, and response were evaluated for prognostic significance against first remission duration. A complete response (CR) was obtained in 61 (80%) dogs, a partial response (PR) was obtained in nine (12%) dogs, and no response (NR) was obtained in five (8%) dogs. The median first remission duration was 25 weeks, with 17% and 5% of the dogs in remission at one and two years, respectively. Observed toxicity was low, with 84% of dogs given an NCI score of 1 or 2. Median survival time for dogs achieving CR was 36 weeks versus four weeks for those achieving PR or NR.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/10997514/